What is the equity of Paradigm Biopharmaceuticals this year?
Paradigm Biopharmaceuticals has equity of 23.81 M AUD this year.
Paradigm Biopharmaceuticals Equity 2024
Paradigm Biopharmaceuticals Equity
23.81 M AUD
Ticker
PAR.AX
ISIN
AU000000PAR5
In 2024, Paradigm Biopharmaceuticals's equity was 23.81 M AUD, a -43.74% increase from the 42.31 M AUD equity in the previous year.
Paradigm Biopharmaceuticals Aktienanalyse
What does Paradigm Biopharmaceuticals do?
Paradigm Biopharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Paradigm Biopharmaceuticals's Equity
Paradigm Biopharmaceuticals's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Paradigm Biopharmaceuticals's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Paradigm Biopharmaceuticals's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Paradigm Biopharmaceuticals's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Paradigm Biopharmaceuticals’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Paradigm Biopharmaceuticals stock
What was the equity of Paradigm Biopharmaceuticals compared to the previous year?
The equity of Paradigm Biopharmaceuticals has increased/decreased by -43.74% decreased compared to the previous year.
What impact does a high equity have on investors of Paradigm Biopharmaceuticals?
A high equity is advantageous for investors of Paradigm Biopharmaceuticals as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Paradigm Biopharmaceuticals?
A low equity can be a risk for investors of Paradigm Biopharmaceuticals, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Paradigm Biopharmaceuticals affect the company?
An increase in equity of Paradigm Biopharmaceuticals can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Paradigm Biopharmaceuticals affect the company?
A reduction in equity of Paradigm Biopharmaceuticals can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Paradigm Biopharmaceuticals?
Some factors that can affect the equity of Paradigm Biopharmaceuticals include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Paradigm Biopharmaceuticals so important for investors?
The equity of Paradigm Biopharmaceuticals is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Paradigm Biopharmaceuticals take to change the equity?
To change equity, Paradigm Biopharmaceuticals can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Paradigm Biopharmaceuticals pay?
Over the past 12 months, Paradigm Biopharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Paradigm Biopharmaceuticals is expected to pay a dividend of 0 AUD.
What is the dividend yield of Paradigm Biopharmaceuticals?
The current dividend yield of Paradigm Biopharmaceuticals is .
When does Paradigm Biopharmaceuticals pay dividends?
Paradigm Biopharmaceuticals pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Paradigm Biopharmaceuticals?
Paradigm Biopharmaceuticals paid dividends every year for the past 0 years.
What is the dividend of Paradigm Biopharmaceuticals?
For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Paradigm Biopharmaceuticals located?
Paradigm Biopharmaceuticals is assigned to the 'Health' sector.
Wann musste ich die Aktien von Paradigm Biopharmaceuticals kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Paradigm Biopharmaceuticals from 9/16/2024 amounting to 0 AUD, you needed to have the stock in your portfolio before the ex-date on 9/16/2024.
When did Paradigm Biopharmaceuticals pay the last dividend?
The last dividend was paid out on 9/16/2024.
What was the dividend of Paradigm Biopharmaceuticals in the year 2023?
In the year 2023, Paradigm Biopharmaceuticals distributed 0 AUD as dividends.
In which currency does Paradigm Biopharmaceuticals pay out the dividend?
The dividends of Paradigm Biopharmaceuticals are distributed in AUD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Paradigm Biopharmaceuticals
Our stock analysis for Paradigm Biopharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Paradigm Biopharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Paradigm Biopharmaceuticals Revenue
- Paradigm Biopharmaceuticals Net Income
- Paradigm Biopharmaceuticals P/E
- Paradigm Biopharmaceuticals P/S
- Paradigm Biopharmaceuticals EBIT
- Paradigm Biopharmaceuticals Dividend
- Paradigm Biopharmaceuticals Stocks
- Paradigm Biopharmaceuticals Market capitalization
- Paradigm Biopharmaceuticals Debt
- Paradigm Biopharmaceuticals Liabilities
- Paradigm Biopharmaceuticals Equity
- Paradigm Biopharmaceuticals AAQS
- Paradigm Biopharmaceuticals Employees
- Paradigm Biopharmaceuticals ROE
- Paradigm Biopharmaceuticals ROA
- Paradigm Biopharmaceuticals ROCE